Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2020-02-18
Buyer: HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (‘UHCW’)
Country: UK
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 31711140 | 33100000 | 33125000 | 33140000: Medical consumables | 33141200
Estimated value: 1200000 GBP
Award criteria: Lowest price

Technical requirements: Framework agreement for the supply of medical devices used in interventional surgical urology and pelvic health procedures. The contract will also include training and clinical support for implementation and through the lifetime of the contract.
Lot 1 is for products used in Ureteric surgery, includes Ureteric Catheters, guide wires, Ureteric Balloons, Ureteric Instruments for Stone Retrieval and Ureteral Stents.
Lot 2 is for single use urology electrodes. this includes monopolar and bipolar resection electrodes only for the use in urology.
Lot 4 is for specialist urinary catheters. This includes 3 way post surgery catheters, intermittent catheters (nelaton) and nephrostomy catheters.
Lot 6 includes single use visualisation innovative devices which allow surgery to take place outside of the operating theatre without the requirements and expense of decontamination processes.
(i) we propose to conclude a framework agreement (FA) with a number of providers all of whom responded to the call for competition in the Contract Notice 2018/S 091-206380 and whose tenders were successful;
(ii) the range of services/supplies that are in scope remains unchanged. The basic structure of the lots remains unchanged. The advertised award procedure was followed and the award criteria remain unchanged. A copy of the draft FA showing the proposed variation is available here;
(iii) tenders have been fully evaluated in accordance with the published evaluation methodology and the information from our purchasing organisations is that the GPO arrangement originally proposed (with a guaranteed purchase value from a fixed number of purchasing organisations) is no longer suitable for their needs because of the economic conditions which now make such specific purchasing commitments inadvisable and that a framework agreement with potentially (but not definitely) a larger number of purchasing organisations, but no minimum purchase levels, is now required;
(iv) this framework agreement will now be limited to 2 years’ duration. The authority intends to meet the requirement for this range of Intervention Urology services/supplies in a replacement general urology framework agreement which is expected to be the subject of a contract notice that will be published in the next 12-18 months;
(v) we consider that the change is permitted by Part 2 of the PCR 2015 without the need for a new contract notice;
(vi) the total value of the framework agreement may be higher than originally estimated for the GPO arrangement. However, we do not consider that the increase in value will exceed 50 % of the original estimated value. The need for this modification has been brought about by circumstances which the authorities (acting diligently) could not have foreseen and it does not alter the overall nature of the contract;
(vii) the draft framework agreement issued with the contract notice will be varied to include consequential provisions setting out the award procedures (mini-competition and direct award) that should be used for call-off contracts. We have considered whether a new call for competition should be issued but consider that the change is not substantial within the meaning of regulation 72(8) of the Public Contracts Regulations 2015 (as amended) and Directive 2014/24/EU, in particular that it does not alter the scope of the FA considerably; does not make it materially different in character and would not have attracted additional participants because of the nature of the market and the high number of operators who expressed an interest;
(viii) we also consider that, insofar as it may be necessary to do so, the authority is also entitled to rely on regulation 32 of the PCR 2015, in particular regulation 32 (2) (c) (extreme urgency) on the basis that the decision is driven entirely by event outside the control of the authority and not attributable to the authority;
(ix) We will not conclude the framework agreement for a period of 10 days beginning with the day after this notice is published.
(i) we propose to conclude a framework agreement (FA) with a number of providers all of whom responded to the call for competition in the Contract Notice 2018/S 091-206380 and whose tenders were successful;


Winner: Bard Ltd
Award value: 1200000